These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32584498)

  • 1. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Nicoli CD; O'Neal WT; Levitan EB; Singleton MJ; Judd SE; Howard G; Safford MM; Soliman EZ
    Heart; 2022 Mar; 108(5):353-359. PubMed ID: 34031160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide.
    Yamauchi R; Morishima I; Okumura K; Kanzaki Y; Morita Y; Takagi K; Nagai H; Watanabe N; Furui K; Yoshioka N; Miyazawa H; Shimojo K; Imaoka T; Sakamoto G; Murohara T
    Europace; 2021 Aug; 23(8):1252-1261. PubMed ID: 33693617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and effectiveness of left atrial appendage closure in atrial fibrillation patients with different types of heart failure.
    Liu L; Yan W; Xu X; Wan C; Liu F; Yao Q; Song L; Wang B; Song Z; Li H
    BMC Cardiovasc Disord; 2024 Aug; 24(1):430. PubMed ID: 39148039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure.
    Zhang M; Zhou J
    BMC Cardiovasc Disord; 2024 Sep; 24(1):495. PubMed ID: 39289613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Oraii A; McIntyre WF; Parkash R; Kowalik K; Razeghi G; Benz AP; Belley-Côté EP; Conen D; Connolly SJ; Tang ASL; Healey JS; Wong JA
    JAMA Cardiol; 2024 Jun; 9(6):545-555. PubMed ID: 38656292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation.
    Tersalvi G; Bossard M; Aeschbacher S; Wiencierz A; Beer JH; Rodondi N; Gencer BF; Reichlin T; Auricchio A; Ammann P; Moschovitis G; Bonati L; Osswald S; Kühne M; Conen D; Kobza R
    Int J Cardiol; 2024 Oct; 412():132320. PubMed ID: 38964549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions.
    Fauchier L; Bisson A; Bodin A
    BMC Med; 2023 Feb; 21(1):54. PubMed ID: 36782248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction.
    Chamberlain AM; Gersh BJ; Alonso A; Kopecky SL; Killian JM; Weston SA; Roger VL
    Heart Rhythm; 2017 Jun; 14(6):791-798. PubMed ID: 28119130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study.
    Zakeri R; Chamberlain AM; Roger VL; Redfield MM
    Circulation; 2013 Sep; 128(10):1085-93. PubMed ID: 23908348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trajectory change of left ventricular ejection fraction after rhythm control for atrial fibrillation in heart failure.
    Si J; Sun Y; Bai L; Tse G; Ding Z; Zhang X; Zhang Y; Chen X; Xia Y; Liu Y
    ESC Heart Fail; 2024 Apr; 11(2):681-691. PubMed ID: 38097279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.
    Gehlken C; Screever EM; Suthahar N; van der Meer P; Westenbrink BD; Coster JE; Van Veldhuisen DJ; de Boer RA; Meijers WC
    ESC Heart Fail; 2021 Aug; 8(4):2458-2466. PubMed ID: 34085774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure.
    Gierula J; Cole CA; Drozd M; Lowry JE; Straw S; Slater TA; Paton MF; Byrom RJ; Garland E; Halliday G; Winsor S; Lyall GK; Birch K; McGinlay M; Sunley E; Grant PJ; Wessels DH; Ketiar EM; Witte KK; Cubbon RM; Kearney MT
    ESC Heart Fail; 2022 Oct; 9(5):3254-3263. PubMed ID: 35790085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.